Rejected at 6:15 p.m. Jan, 14, 2024 ] by Ahmed7
Author: ma7moudgamal66
Related Note: 1461634662371 1
Rationale for change

A reminder that lactulose is used in conjunction with rafiximin in HE
Source: UWorld - Step 1 11661

Rejection reason

Please resubmit with an acceptable rationale. Please review suggestion guidelines, specifically rule #2: http://www.theanking.com/decks/step/suggestions

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::25602 #AK_Step1_v12::#FirstAid::09_Gastrointestinal::05_Pharm::12_Anticonstipation_drugs::*Laxatives #AK_Step1_v12::#UWorld::Step::11661 #AK_Step1_v12::#SketchyPath::06_Hepatobiliary::02_Liver_Disease::01_Cirrhosis_-_Pathogenesis_&_Clinical_Manifestations #AK_Step1_v12::#Pathoma::11_Exocrine,Pancreas,Gallbladder,&Liver::03_Liver::cirrhosis_and_tumors #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::03_Gastrointestinal::03_Hepatobiliary::05_Cirrhosis #AK_Step1_v12::#Bootcamp::Gastroenterology::05_Liver::19_Hyperammonemia_TIPS_Procedure_and_Congestive_Hepatopathy_Histopathology #AK_Step2_v12::#OME::01_Medicine::03_Gastroenterology::13_Cirrhosis_Complications #PANCE::GI::hepatic_disorders #AK_Step2_v12::#B&B::06_GI::02_Liver::03_Cirrhosis #AK_Step1_v12::#Bootcamp::Gastroenterology::05_Liver::18_Portal_HTN_Presentation_and_SAAG #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::31_Cirrhosis_and_portal_hypertension::*Hepatic_Encephalopathy #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::11_Pathology::06_Gastrointestinal_Pathology::13_Cirrhosis_Liver_Cancer #AK_Step1_v12::#OME::04_Organ_Systems::03_Gastrointestinal::03_Hepatobiliary::05_Cirrhosis #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::01_GI::03_Laxatives #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::23_Rifamycins #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#Resources_by_rotation::IM::ome::gi::cirrhosis+complications #AK_Step1_v12::#Physeo::09_Pharm::11_Gastrointestinal::12_Laxatives #AK_Step2_v12::#OME::01_Medicine::03_Gastroenterology::12_Cirrhosis #PANCE::EOR::EM #AK_Step1_v12::#SketchyBiochem::01_Metabolism::02_Amino_Acids_&_Proteins::07_Urea_Cycle_Hyperammonemia_Ornithine_Transcarbamylase(OTC)_Deficiency #AK_Step2_v12::#AMBOSS::sN0tcg #AK_Step1_v12::^Systems::GI::pathology #AK_Step1_v12::#NBME::26 #AK_Step1_v12::^Systems::GI::pharm #AK_Step2_v12::#AMBOSS::2w0TRR #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::02_Laxatives_&_Antidiarrheal_Agents_[Old_Version] #AK_Step1_v12::#AMBOSS::aTaQ6P #AK_Step1_v12::#FirstAid::09_Gastrointestinal::04_Pathology::38_Hepatic_encephalopathy #AK_Step2_v12::#SketchyIM::11_Hepatobiliary::03_Cirrhosis::02_Cirrhosis_Complications_&_Management